Everolimus
NDC 0054-0472, Everolimus, tablet, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0054-0472
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206133
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0472 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS.75 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0054-0472-21 | 00054047221 | 60 TABLET in 1 BOTTLE (0054-0472-21) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cf2dd54b-7a1d-4401-9a01-75e68235e433Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0054-0472NADAC price for package 00054047221
GET /v1/drugs/nadac/00054047221
Use it
Look up 0054-0472 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0472 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0054-0472. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.